Published in Leuk Res on February 21, 2007
Pathobiology of anaplastic large cell lymphoma. Adv Hematol (2011) 0.93
Pathobiology of ALK-negative anaplastic large cell lymphoma. Pediatr Rep (2011) 0.77
Relevance of Fusion Genes in Pediatric Cancers: Toward Precision Medicine. Mol Ther Nucleic Acids (2017) 0.75
Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia. J Clin Oncol (2010) 1.79
World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group. Pediatr Blood Cancer (2008) 1.48
Posterior Reversible Encephalopathy Syndrome (PRES) in 5-year-old girl with nephrotic syndrome. Neuro Endocrinol Lett (2010) 1.38
Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Virchows Arch (2001) 1.23
Demographic and risk factors in patients with head and neck tumors. J Med Virol (2009) 1.10
Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network. J Hematop (2009) 1.07
Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors. Mod Pathol (2003) 1.03
Combined biodifferentiating and antiangiogenic oral metronomic therapy is feasible and effective in relapsed solid tumors in children: single-center pilot study. Onkologie (2006) 1.03
Somatic TP53 mutation mosaicism in a patient with Li-Fraumeni syndrome. Am J Med Genet A (2009) 0.97
A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase IIalpha, and TPX2): an immunohistochemical correlation, testing, and optimizing for mantle cell lymphoma. Virchows Arch (2010) 0.96
Angiosarcoma of the thyroid. Eur Arch Otorhinolaryngol (2008) 0.94
Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas. Int J Cancer (2011) 0.93
Identification of potential human oncogenes by mapping the common viral integration sites in avian nephroblastoma. Cancer Res (2006) 0.92
Efficacy of pregabalin in neuropathic pain in paediatric oncological patients. Eur J Paediatr Neurol (2008) 0.92
Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: experiences and preliminary recommendations from the European childhood lymphoma pathology panel. Am J Surg Pathol (2011) 0.91
Galectin-3 - an emerging prognostic indicator in advanced head and neck carcinoma. Eur J Cancer (2004) 0.90
Coincidence of thyroid tumor and thyroglossal duct remnants. Review of the literature and presentation of three cases. Tumori (2003) 0.88
Breast cancer: role of polymorphisms in biotransformation enzymes. Eur J Hum Genet (2004) 0.88
Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. Eur J Cancer (2005) 0.87
Localization of genetic elements of intact and derivative chromosome 11 and 22 territories in nuclei of Ewing sarcoma cells. J Struct Biol (2006) 0.87
Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: increased expression of galectin-1 and induction of poor prognosis factors. Int J Cancer (2012) 0.86
A Li-Fraumeni syndrome family with retained heterozygosity for a germline TP53 mutation in two tumors. Cancer Genet Cytogenet (2003) 0.85
RNA expression of cytochrome P450 in breast cancer patients. Anticancer Res (2008) 0.84
Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma. Virchows Arch (2010) 0.83
Tumor-infiltrating lymphocytes and dendritic cells in human colorectal cancer: their relationship to KRAS mutational status and disease recurrence. Hum Immunol (2011) 0.82
Molecular cytogenetic characterization in four pediatric pheochromocytomas and paragangliomas. Pathol Oncol Res (2011) 0.81
Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients. Pharmacogenet Genomics (2008) 0.81
Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a "Watch and wait" strategy after complete resection. Ann Hematol (2013) 0.81
Giant angiofibromas in tuberous sclerosis complex: a possible role for localized lymphedema in their pathogenesis. J Am Acad Dermatol (2012) 0.80
Malignant peripheral primitive neuroectodermal tumor of the kidney. Cancer Genet Cytogenet (2002) 0.80
Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma. Cancer Genet Cytogenet (2009) 0.80
Relative quantification of ERBB2 mRNA in invasive duct carcinoma of the breast: correlation with ERBB-2 protein expression and ERBB2 gene copy number. Pathol Res Pract (2003) 0.79
Quantitative measurement of cyclin D1 mRNA, a potent diagnostic tool to separate mantle cell lymphoma from other B-cell lymphoproliferative disorders. Diagn Mol Pathol (2008) 0.79
Importance of transcript levels of caspase-2 isoforms S and L for breast carcinoma progression. Future Oncol (2013) 0.79
Teratoma in an adolescent with malignant transformation into embryonal rhabdomyosarcoma: case report. J Pediatr Hematol Oncol (2006) 0.78
Loss of adhesion/growth-regulatory galectin-9 from squamous cell epithelium in head and neck carcinomas. J Oral Pathol Med (2012) 0.78
The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients. Medicine (Baltimore) (2014) 0.77
A novel variant of SYT-SSX1 fusion gene in a case of spindle cell synovial sarcoma. Diagn Mol Pathol (2007) 0.77
NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and expression do not cosegregate with clinico-pathological characteristics of human mammary tumors. Pharmacogenet Genomics (2009) 0.76
A modified approach for I-FISH evaluation of ERBB2 (HER-2) gene copy numbers in breast carcinomas: comparison with HER-2/CEP17 ratio system. J Cancer Res Clin Oncol (2006) 0.76
Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease. Eur J Nucl Med Mol Imaging (2006) 0.76
The association of taxane resistance genes with the clinical course of ovarian carcinoma. Genomics (2013) 0.76
Cytogenetic and array comparative genomic hybridization analysis of a series of hepatoblastomas. Cancer Genet Cytogenet (2009) 0.75
Correlation of expression of nuclear proteins pKi67 and p63 with lectin histochemical features in head and neck squamous cell cancer. Int J Oncol (2005) 0.75
Comparative analysis of alpha2,3/2,6-linked N-acetylneuraminic acid and cytokeratin expression in head and neck squamous cell carcinoma. Oncol Rep (2004) 0.75
[Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs]. Cesk Patol (2017) 0.75
Quantitative monitoring of cyclin D1 expression: a molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma. Int J Cancer (2008) 0.75
[Sinus histiocytosis with massive lymphadenopathy: FDG-PET/CT documented partial remission after treatment with 2-chlorodeoxyadenosine]. Vnitr Lek (2016) 0.75
Lipoblastoma of kidney in a child. J Pediatr Surg (2006) 0.75
The use of formalin-fixed, paraffin-embedded lymph node samples for the detection of minimal residual disease in mantle cell lymphoma. Br J Haematol (2014) 0.75
Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases. Virchows Arch (2014) 0.75
[Soft tissue tumors - the view of the molecular biologist]. Cesk Patol (2014) 0.75
Molecular and immunohistochemical analysis of ERBB2 expression in correlation with proliferation rate in synovial sarcoma. Diagn Mol Pathol (2007) 0.75
[Diagnostics in hematopathology. Preface]. Cesk Patol (2011) 0.75
[Not Available]. Cesk Patol (2013) 0.75
[Fluorescence in situ hybridization on histologic sections]. Cesk Patol (2013) 0.75
Loss of heterozygosity and human telomerase reverse transcriptase (hTERT) expression in bronchial mucosa of heavy smokers. Cancer (2007) 0.75
Expression of the active caspase-3 in children and adolescents with classical Hodgkin lymphoma. Cesk Patol (2014) 0.75
[A complex diagnostic approach in lymphomas: practical aspect in short case reports]. Cesk Patol (2014) 0.75
Primary mediastinal (thymic) large B-cell lymphoma with a der(14)t(8;14)(q24;q32) and a translocation of MYC to the derivative chromosome 14 with a deleted IgH locus. Cancer Genet Cytogenet (2006) 0.75
[Periosteal osteosarcoma - personal experience with five cases]. Cesk Patol (2015) 0.75
[Not Available]. Cesk Patol (2014) 0.75
Transcript expression and genetic variability analysis of caspases in breast carcinomas suggests CASP9 as the most interesting target. Clin Chem Lab Med (2017) 0.75